These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 29507694)
1. Notoginsenoside R1 ameliorates diabetic encephalopathy by activating the Nrf2 pathway and inhibiting NLRP3 inflammasome activation. Zhai Y; Meng X; Luo Y; Wu Y; Ye T; Zhou P; Ding S; Wang M; Lu S; Zhu L; Sun G; Sun X Oncotarget; 2018 Feb; 9(10):9344-9363. PubMed ID: 29507694 [TBL] [Abstract][Full Text] [Related]
2. Suppression of NADPH oxidase- and mitochondrion-derived superoxide by Notoginsenoside R1 protects against cerebral ischemia-reperfusion injury through estrogen receptor-dependent activation of Akt/Nrf2 pathways. Meng X; Wang M; Wang X; Sun G; Ye J; Xu H; Sun X Free Radic Res; 2014 Jul; 48(7):823-38. PubMed ID: 24720662 [TBL] [Abstract][Full Text] [Related]
3. Notoginsenoside R1-mediated neuroprotection involves estrogen receptor-dependent crosstalk between Akt and ERK1/2 pathways: a novel mechanism of Nrf2/ARE signaling activation. Meng X; Sun G; Ye J; Xu H; Wang H; Sun X Free Radic Res; 2014 Apr; 48(4):445-60. PubMed ID: 24437944 [TBL] [Abstract][Full Text] [Related]
4. Notoginsenoside R1 Protects Against Diabetic Cardiomyopathy Through Activating Estrogen Receptor α and Its Downstream Signaling. Zhang B; Zhang J; Zhang C; Zhang X; Ye J; Kuang S; Sun G; Sun X Front Pharmacol; 2018; 9():1227. PubMed ID: 30450046 [TBL] [Abstract][Full Text] [Related]
5. Gastrodin Alleviates Cognitive Dysfunction and Depressive-Like Behaviors by Inhibiting ER Stress and NLRP3 Inflammasome Activation in db/db Mice. Ye T; Meng X; Wang R; Zhang C; He S; Sun G; Sun X Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544722 [TBL] [Abstract][Full Text] [Related]
6. Notoginsenoside R1 Ameliorates Diabetic Retinopathy through PINK1-Dependent Activation of Mitophagy. Zhou P; Xie W; Meng X; Zhai Y; Dong X; Zhang X; Sun G; Sun X Cells; 2019 Mar; 8(3):. PubMed ID: 30832367 [No Abstract] [Full Text] [Related]
7. Notoginsenoside R1 Protects db/db Mice against Diabetic Nephropathy via Upregulation of Nrf2-Mediated HO-1 Expression. Zhang B; Zhang X; Zhang C; Shen Q; Sun G; Sun X Molecules; 2019 Jan; 24(2):. PubMed ID: 30634720 [TBL] [Abstract][Full Text] [Related]
8. Integrating network pharmacology and experimental models to identify notoginsenoside R1 ameliorates atherosclerosis by inhibiting macrophage NLRP3 inflammasome activation. Yu J; Hu J; Baldini M; Lei H; Li L; Luo S; Wu J; Liu X; Shan D; Xie Y; Fang H; Yu J J Nat Med; 2024 Jun; 78(3):644-654. PubMed ID: 38409483 [TBL] [Abstract][Full Text] [Related]
9. Pre-treatment with notoginsenoside R1 from Panax notoginseng protects against high-altitude-induced pulmonary edema by inhibiting pyroptosis through the NLRP3/caspase-1/GSDMD pathway. Huang D; Wang Y; Pei C; Zhang X; Shen Z; Jia N; Zhao S; Li G; Wang Z Biomed Pharmacother; 2024 Nov; 180():117512. PubMed ID: 39353320 [TBL] [Abstract][Full Text] [Related]
10. Notoginsenoside R1, a metabolite from Panax notoginseng (Burkill) F.H.Chen, stimulates insulin secretion through activation of phosphatidylinositol 3-kinase (PI3K)/Akt pathway. Al-Romaiyan A; Barakat A; Marafie SK; Masocha W Front Pharmacol; 2024; 15():1478917. PubMed ID: 39399466 [TBL] [Abstract][Full Text] [Related]
11. Notoginsenoside R1 Protects Against High Glucose-Induced Cell Injury Through AMPK/Nrf2 and Downstream HO-1 Signaling. Du F; Huang H; Cao Y; Ran Y; Wu Q; Chen B Front Cell Dev Biol; 2021; 9():791643. PubMed ID: 34926469 [TBL] [Abstract][Full Text] [Related]
12. Effect of NGR1 on the Atopic Dermatitis Model and its Mechanisms. Wang M; Ma J Open Med (Wars); 2019; 14():847-853. PubMed ID: 31737789 [TBL] [Abstract][Full Text] [Related]
13. Notoginsenoside R1 attenuates sevoflurane-induced neurotoxicity. Zhang Y; Zhao Y; Ran Y; Guo J; Cui H; Liu S Transl Neurosci; 2020; 11(1):215-226. PubMed ID: 33335762 [TBL] [Abstract][Full Text] [Related]
14. Notoginsenoside R1-loaded mesoporous silica nanoparticles targeting the site of injury through inflammatory cells improves heart repair after myocardial infarction. Li H; Zhu J; Xu YW; Mou FF; Shan XL; Wang QL; Liu BN; Ning K; Liu JJ; Wang YC; Mi JX; Wei X; Shao SJ; Cui GH; Lu R; Guo HD Redox Biol; 2022 Aug; 54():102384. PubMed ID: 35777198 [TBL] [Abstract][Full Text] [Related]
15. Notoginsenoside R1 alleviates spinal cord injury by inhibiting oxidative stress, neuronal apoptosis, and inflammation via activating the nuclear factor erythroid 2 related factor 2/heme oxygenase-1 signaling pathway. Luo H; Bao Z; Zhou M; Chen Y; Huang Z Neuroreport; 2022 Aug; 33(11):451-462. PubMed ID: 35775321 [TBL] [Abstract][Full Text] [Related]
16. Effects of notoginsenoside R1 on attenuating depressive behavior induced by chronic stress in rats through induction of PI3K/AKT/NF-κB pathway. Zhan Q; Wu Y; Liu L Drug Dev Res; 2022 Feb; 83(1):97-104. PubMed ID: 34173680 [TBL] [Abstract][Full Text] [Related]
17. Notoginsenoside R1 Reverses Abnormal Autophagy in Hippocampal Neurons of Mice With Sleep Deprivation Through Melatonin Receptor 1A. Cao Y; Li Q; Zhou A; Ke Z; Chen S; Li M; Gong Z; Wang Z; Wu X Front Pharmacol; 2021; 12():719313. PubMed ID: 34603030 [TBL] [Abstract][Full Text] [Related]
18. Panax notoginseng saponins provide neuroprotection by regulating NgR1/RhoA/ROCK2 pathway expression, in vitro and in vivo. Shi X; Yu W; Yang T; Liu W; Zhao Y; Sun Y; Chai L; Gao Y; Dong B; Zhu L J Ethnopharmacol; 2016 Aug; 190():301-12. PubMed ID: 27288754 [TBL] [Abstract][Full Text] [Related]
19. Protective Effect of NGR1 against Glutamate-Induced Cytotoxicity in HT22 Hippocampal Neuronal Cells by Upregulating the SIRT1/Wnt/ Wang D; Gao B; Yang T; Sun H; Ran X; Lin W Evid Based Complement Alternat Med; 2021; 2021():4358163. PubMed ID: 34956378 [TBL] [Abstract][Full Text] [Related]
20. Effects of the Combination of the Main Active Components of Astragalus and Panax notoginseng on Inflammation and Apoptosis of Nerve Cell after Cerebral Ischemia-Reperfusion. Huang XP; Ding H; Lu JD; Tang YH; Deng BX; Deng CQ Am J Chin Med; 2015; 43(7):1419-38. PubMed ID: 26477799 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]